What are Somatostatin receptor targeting agent drugs?

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Somatostatin receptor targeting agent drugs are pharmacologic agents that share a common mechanism (typically targeting Somatostatin receptor). 0 are currently marketed, with 5 more in clinical development.

Somatostatin receptor targeting agent

0 marketed 1 in Phase 2 4 in Phase 1

This page covers all Somatostatin receptor targeting agent drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Somatostatin receptor.

Targets

Somatostatin receptor

Phase 2 pipeline (1)

64Cu-DOTA-AE105 · Curasight · Oncology
Somatostatin receptor targeting

Phase 1 pipeline (4)

64Cu-DOTA-TLX592 · Telix Pharmaceuticals (Innovations) Pty Limited · Oncology
Somatostatin receptor targeting
177Lu-DOTA-EB-TATE · Molecular Targeting Technologies, Inc. · Oncology
Somatostatin receptor targeting
131I-IPA · Telix Pharmaceuticals (Innovations) Pty Limited · Oncology
Iodine-131 labelled peptide for targeted radionuclide therapy
153Sm-DOTMP · Telix Pharmaceuticals (Innovations) Pty Limited · Oncology
A radioligand targeting somatostatin receptors

Patent intelligence

somatostatin receptor targeting agent patent landscape — aggregated cliff calendar, attackable patents, originator estates